Global First in Human (FIH) Studies Market Growth (Status and Outlook) 2025-2031

Product Code: 1704980

Industry: Medical Care

Published: Jul 12,2025

Pages: 158

Delivery Time: 2-3 business days

Global First in Human (FIH) Studies Market Growth (Status and Outlook) 2025-2031

Product Code: 1704980

Industry: Medical Care

Published: Jul 12,2025

Pages: 158

Delivery Time: 2-3 business days

Select A Format

Single User License

USD3660

Multi Users License

USD5490

Corporate Users License

USD7320

Buy Now

Add To Cart

Or More Options：

PDF Download

Sample Request

Custom Request

Provide market analysis and obtain sources of data reports

Description

According to this study, the global First in Human (FIH) Studies market size will reach US$ 157 million by 2031.

First in Human (FIH) Studies are the earliest phase of clinical research in which a new drug, biologic, or medical intervention is tested in humans for the first time. These studies are designed primarily to assess safety, tolerability, pharmacokinetics, and initial pharmacodynamic effects in a small group of participants, typically healthy volunteers or, in certain cases, patients. FIH studies are conducted after preclinical testing has demonstrated a reasonable level of safety and potential therapeutic benefit. They play a critical role in determining how the human body responds to a new treatment and guide decisions for further clinical development.

United States market for First in Human (FIH) Studies is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for First in Human (FIH) Studies is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for First in Human (FIH) Studies is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key First in Human (FIH) Studies players cover Precision for Medicine, Altasciences, hVIVO, QPS Holdings, Worldwide Clinical Trials, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “First in Human (FIH) Studies Industry Forecast” looks at past sales and reviews total world First in Human (FIH) Studies sales in 2024, providing a comprehensive analysis by region and market sector of projected First in Human (FIH) Studies sales for 2025 through 2031. With First in Human (FIH) Studies sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world First in Human (FIH) Studies industry.

This Insight Report provides a comprehensive analysis of the global First in Human (FIH) Studies landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on First in Human (FIH) Studies portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global First in Human (FIH) Studies market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for First in Human (FIH) Studies and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global First in Human (FIH) Studies.

This report presents a comprehensive overview, market shares, and growth opportunities of First in Human (FIH) Studies market by product type, application, key players and key regions and countries.

Segmentation by Type:
    Healthy Volunteer Studies
    Patient Population Studies

Segmentation by Application:
    Pharmaceutical
    Vaccine
    Others

This report also splits the market by region:
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

    Precision for Medicine
    Altasciences
    hVIVO
    QPS Holdings
    Worldwide Clinical Trials
    Veeda Lifesciences
    CMAX
    Hammersmith Medicines Research
    Allucent
    Aixial Group
    Icon Group
    BioPharma Services
    Simbec-Orion
    The Micron Group
    BDD
    TRACER
    Sofpromed
    Datapharm Australia
    3S Pharma
    bioaccess
    Pharmaron
    WuXi Clinical (WuXi AppTec)

Table Of Contents

1 Scope of the Report
    1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered
    1.8 Market Estimation Caveats

2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global First in Human (FIH) Studies Market Size (2020-2031)
        2.1.2 First in Human (FIH) Studies Market Size CAGR by Region (2020 VS 2024 VS 2031)
        2.1.3 World Current & Future Analysis for First in Human (FIH) Studies by Country/Region (2020, 2024 & 2031)
    2.2 First in Human (FIH) Studies Segment by Type
        2.2.1 Healthy Volunteer Studies
        2.2.2 Patient Population Studies
    2.3 First in Human (FIH) Studies Market Size by Type
        2.3.1 First in Human (FIH) Studies Market Size CAGR by Type (2020 VS 2024 VS 2031)
        2.3.2 Global First in Human (FIH) Studies Market Size Market Share by Type (2020-2025)
    2.4 First in Human (FIH) Studies Segment by Application
        2.4.1 Pharmaceutical
        2.4.2 Vaccine
        2.4.3 Others
    2.5 First in Human (FIH) Studies Market Size by Application
        2.5.1 First in Human (FIH) Studies Market Size CAGR by Application (2020 VS 2024 VS 2031)
        2.5.2 Global First in Human (FIH) Studies Market Size Market Share by Application (2020-2025)

3 First in Human (FIH) Studies Market Size by Player
    3.1 First in Human (FIH) Studies Market Size Market Share by Player
        3.1.1 Global First in Human (FIH) Studies Revenue by Player (2020-2025)
        3.1.2 Global First in Human (FIH) Studies Revenue Market Share by Player (2020-2025)
    3.2 Global First in Human (FIH) Studies Key Players Head office and Products Offered
    3.3 Market Concentration Rate Analysis
        3.3.1 Competition Landscape Analysis
        3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
    3.4 New Products and Potential Entrants
    3.5 Mergers & Acquisitions, Expansion

4 First in Human (FIH) Studies by Region
    4.1 First in Human (FIH) Studies Market Size by Region (2020-2025)
    4.2 Global First in Human (FIH) Studies Annual Revenue by Country/Region (2020-2025)
    4.3 Americas First in Human (FIH) Studies Market Size Growth (2020-2025)
    4.4 APAC First in Human (FIH) Studies Market Size Growth (2020-2025)
    4.5 Europe First in Human (FIH) Studies Market Size Growth (2020-2025)
    4.6 Middle East & Africa First in Human (FIH) Studies Market Size Growth (2020-2025)

5 Americas
    5.1 Americas First in Human (FIH) Studies Market Size by Country (2020-2025)
    5.2 Americas First in Human (FIH) Studies Market Size by Type (2020-2025)
    5.3 Americas First in Human (FIH) Studies Market Size by Application (2020-2025)
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil

6 APAC
    6.1 APAC First in Human (FIH) Studies Market Size by Region (2020-2025)
    6.2 APAC First in Human (FIH) Studies Market Size by Type (2020-2025)
    6.3 APAC First in Human (FIH) Studies Market Size by Application (2020-2025)
    6.4 China
    6.5 Japan
    6.6 South Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia

7 Europe
    7.1 Europe First in Human (FIH) Studies Market Size by Country (2020-2025)
    7.2 Europe First in Human (FIH) Studies Market Size by Type (2020-2025)
    7.3 Europe First in Human (FIH) Studies Market Size by Application (2020-2025)
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia

8 Middle East & Africa
    8.1 Middle East & Africa First in Human (FIH) Studies by Region (2020-2025)
    8.2 Middle East & Africa First in Human (FIH) Studies Market Size by Type (2020-2025)
    8.3 Middle East & Africa First in Human (FIH) Studies Market Size by Application (2020-2025)
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries

9 Market Drivers, Challenges and Trends
    9.1 Market Drivers & Growth Opportunities
    9.2 Market Challenges & Risks
    9.3 Industry Trends

10 Global First in Human (FIH) Studies Market Forecast
    10.1 Global First in Human (FIH) Studies Forecast by Region (2026-2031)
        10.1.1 Global First in Human (FIH) Studies Forecast by Region (2026-2031)
        10.1.2 Americas First in Human (FIH) Studies Forecast
        10.1.3 APAC First in Human (FIH) Studies Forecast
        10.1.4 Europe First in Human (FIH) Studies Forecast
        10.1.5 Middle East & Africa First in Human (FIH) Studies Forecast
    10.2 Americas First in Human (FIH) Studies Forecast by Country (2026-2031)
        10.2.1 United States Market First in Human (FIH) Studies Forecast
        10.2.2 Canada Market First in Human (FIH) Studies Forecast
        10.2.3 Mexico Market First in Human (FIH) Studies Forecast
        10.2.4 Brazil Market First in Human (FIH) Studies Forecast
    10.3 APAC First in Human (FIH) Studies Forecast by Region (2026-2031)
        10.3.1 China First in Human (FIH) Studies Market Forecast
        10.3.2 Japan Market First in Human (FIH) Studies Forecast
        10.3.3 Korea Market First in Human (FIH) Studies Forecast
        10.3.4 Southeast Asia Market First in Human (FIH) Studies Forecast
        10.3.5 India Market First in Human (FIH) Studies Forecast
        10.3.6 Australia Market First in Human (FIH) Studies Forecast
    10.4 Europe First in Human (FIH) Studies Forecast by Country (2026-2031)
        10.4.1 Germany Market First in Human (FIH) Studies Forecast
        10.4.2 France Market First in Human (FIH) Studies Forecast
        10.4.3 UK Market First in Human (FIH) Studies Forecast
        10.4.4 Italy Market First in Human (FIH) Studies Forecast
        10.4.5 Russia Market First in Human (FIH) Studies Forecast
    10.5 Middle East & Africa First in Human (FIH) Studies Forecast by Region (2026-2031)
        10.5.1 Egypt Market First in Human (FIH) Studies Forecast
        10.5.2 South Africa Market First in Human (FIH) Studies Forecast
        10.5.3 Israel Market First in Human (FIH) Studies Forecast
        10.5.4 Turkey Market First in Human (FIH) Studies Forecast
    10.6 Global First in Human (FIH) Studies Forecast by Type (2026-2031)
    10.7 Global First in Human (FIH) Studies Forecast by Application (2026-2031)
        10.7.1 GCC Countries Market First in Human (FIH) Studies Forecast

11 Key Players Analysis
    11.1 Precision for Medicine
        11.1.1 Precision for Medicine Company Information
        11.1.2 Precision for Medicine First in Human (FIH) Studies Product Offered
        11.1.3 Precision for Medicine First in Human (FIH) Studies Revenue, Gross Margin and Market Share (2020-2025)
        11.1.4 Precision for Medicine Main Business Overview
        11.1.5 Precision for Medicine Latest Developments
    11.2 Altasciences
        11.2.1 Altasciences Company Information
        11.2.2 Altasciences First in Human (FIH) Studies Product Offered
        11.2.3 Altasciences First in Human (FIH) Studies Revenue, Gross Margin and Market Share (2020-2025)
        11.2.4 Altasciences Main Business Overview
        11.2.5 Altasciences Latest Developments
    11.3 hVIVO
        11.3.1 hVIVO Company Information
        11.3.2 hVIVO First in Human (FIH) Studies Product Offered
        11.3.3 hVIVO First in Human (FIH) Studies Revenue, Gross Margin and Market Share (2020-2025)
        11.3.4 hVIVO Main Business Overview
        11.3.5 hVIVO Latest Developments
    11.4 QPS Holdings
        11.4.1 QPS Holdings Company Information
        11.4.2 QPS Holdings First in Human (FIH) Studies Product Offered
        11.4.3 QPS Holdings First in Human (FIH) Studies Revenue, Gross Margin and Market Share (2020-2025)
        11.4.4 QPS Holdings Main Business Overview
        11.4.5 QPS Holdings Latest Developments
    11.5 Worldwide Clinical Trials
        11.5.1 Worldwide Clinical Trials Company Information
        11.5.2 Worldwide Clinical Trials First in Human (FIH) Studies Product Offered
        11.5.3 Worldwide Clinical Trials First in Human (FIH) Studies Revenue, Gross Margin and Market Share (2020-2025)
        11.5.4 Worldwide Clinical Trials Main Business Overview
        11.5.5 Worldwide Clinical Trials Latest Developments
    11.6 Veeda Lifesciences
        11.6.1 Veeda Lifesciences Company Information
        11.6.2 Veeda Lifesciences First in Human (FIH) Studies Product Offered
        11.6.3 Veeda Lifesciences First in Human (FIH) Studies Revenue, Gross Margin and Market Share (2020-2025)
        11.6.4 Veeda Lifesciences Main Business Overview
        11.6.5 Veeda Lifesciences Latest Developments
    11.7 CMAX
        11.7.1 CMAX Company Information
        11.7.2 CMAX First in Human (FIH) Studies Product Offered
        11.7.3 CMAX First in Human (FIH) Studies Revenue, Gross Margin and Market Share (2020-2025)
        11.7.4 CMAX Main Business Overview
        11.7.5 CMAX Latest Developments
    11.8 Hammersmith Medicines Research
        11.8.1 Hammersmith Medicines Research Company Information
        11.8.2 Hammersmith Medicines Research First in Human (FIH) Studies Product Offered
        11.8.3 Hammersmith Medicines Research First in Human (FIH) Studies Revenue, Gross Margin and Market Share (2020-2025)
        11.8.4 Hammersmith Medicines Research Main Business Overview
        11.8.5 Hammersmith Medicines Research Latest Developments
    11.9 Allucent
        11.9.1 Allucent Company Information
        11.9.2 Allucent First in Human (FIH) Studies Product Offered
        11.9.3 Allucent First in Human (FIH) Studies Revenue, Gross Margin and Market Share (2020-2025)
        11.9.4 Allucent Main Business Overview
        11.9.5 Allucent Latest Developments
    11.10 Aixial Group
        11.10.1 Aixial Group Company Information
        11.10.2 Aixial Group First in Human (FIH) Studies Product Offered
        11.10.3 Aixial Group First in Human (FIH) Studies Revenue, Gross Margin and Market Share (2020-2025)
        11.10.4 Aixial Group Main Business Overview
        11.10.5 Aixial Group Latest Developments
    11.11 Icon Group
        11.11.1 Icon Group Company Information
        11.11.2 Icon Group First in Human (FIH) Studies Product Offered
        11.11.3 Icon Group First in Human (FIH) Studies Revenue, Gross Margin and Market Share (2020-2025)
        11.11.4 Icon Group Main Business Overview
        11.11.5 Icon Group Latest Developments
    11.12 BioPharma Services
        11.12.1 BioPharma Services Company Information
        11.12.2 BioPharma Services First in Human (FIH) Studies Product Offered
        11.12.3 BioPharma Services First in Human (FIH) Studies Revenue, Gross Margin and Market Share (2020-2025)
        11.12.4 BioPharma Services Main Business Overview
        11.12.5 BioPharma Services Latest Developments
    11.13 Simbec-Orion
        11.13.1 Simbec-Orion Company Information
        11.13.2 Simbec-Orion First in Human (FIH) Studies Product Offered
        11.13.3 Simbec-Orion First in Human (FIH) Studies Revenue, Gross Margin and Market Share (2020-2025)
        11.13.4 Simbec-Orion Main Business Overview
        11.13.5 Simbec-Orion Latest Developments
    11.14 The Micron Group
        11.14.1 The Micron Group Company Information
        11.14.2 The Micron Group First in Human (FIH) Studies Product Offered
        11.14.3 The Micron Group First in Human (FIH) Studies Revenue, Gross Margin and Market Share (2020-2025)
        11.14.4 The Micron Group Main Business Overview
        11.14.5 The Micron Group Latest Developments
    11.15 BDD
        11.15.1 BDD Company Information
        11.15.2 BDD First in Human (FIH) Studies Product Offered
        11.15.3 BDD First in Human (FIH) Studies Revenue, Gross Margin and Market Share (2020-2025)
        11.15.4 BDD Main Business Overview
        11.15.5 BDD Latest Developments
    11.16 TRACER
        11.16.1 TRACER Company Information
        11.16.2 TRACER First in Human (FIH) Studies Product Offered
        11.16.3 TRACER First in Human (FIH) Studies Revenue, Gross Margin and Market Share (2020-2025)
        11.16.4 TRACER Main Business Overview
        11.16.5 TRACER Latest Developments
    11.17 Sofpromed
        11.17.1 Sofpromed Company Information
        11.17.2 Sofpromed First in Human (FIH) Studies Product Offered
        11.17.3 Sofpromed First in Human (FIH) Studies Revenue, Gross Margin and Market Share (2020-2025)
        11.17.4 Sofpromed Main Business Overview
        11.17.5 Sofpromed Latest Developments
    11.18 Datapharm Australia
        11.18.1 Datapharm Australia Company Information
        11.18.2 Datapharm Australia First in Human (FIH) Studies Product Offered
        11.18.3 Datapharm Australia First in Human (FIH) Studies Revenue, Gross Margin and Market Share (2020-2025)
        11.18.4 Datapharm Australia Main Business Overview
        11.18.5 Datapharm Australia Latest Developments
    11.19 3S Pharma
        11.19.1 3S Pharma Company Information
        11.19.2 3S Pharma First in Human (FIH) Studies Product Offered
        11.19.3 3S Pharma First in Human (FIH) Studies Revenue, Gross Margin and Market Share (2020-2025)
        11.19.4 3S Pharma Main Business Overview
        11.19.5 3S Pharma Latest Developments
    11.20 bioaccess
        11.20.1 bioaccess Company Information
        11.20.2 bioaccess First in Human (FIH) Studies Product Offered
        11.20.3 bioaccess First in Human (FIH) Studies Revenue, Gross Margin and Market Share (2020-2025)
        11.20.4 bioaccess Main Business Overview
        11.20.5 bioaccess Latest Developments
    11.21 Pharmaron
        11.21.1 Pharmaron Company Information
        11.21.2 Pharmaron First in Human (FIH) Studies Product Offered
        11.21.3 Pharmaron First in Human (FIH) Studies Revenue, Gross Margin and Market Share (2020-2025)
        11.21.4 Pharmaron Main Business Overview
        11.21.5 Pharmaron Latest Developments
    11.22 WuXi Clinical (WuXi AppTec)
        11.22.1 WuXi Clinical (WuXi AppTec) Company Information
        11.22.2 WuXi Clinical (WuXi AppTec) First in Human (FIH) Studies Product Offered
        11.22.3 WuXi Clinical (WuXi AppTec) First in Human (FIH) Studies Revenue, Gross Margin and Market Share (2020-2025)
        11.22.4 WuXi Clinical (WuXi AppTec) Main Business Overview
        11.22.5 WuXi Clinical (WuXi AppTec) Latest Developments

12 Research Findings and Conclusion

List Of Tables

List of Tables
 Table 1. First in Human (FIH) Studies Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
 Table 2. First in Human (FIH) Studies Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
 Table 3. Major Players of Healthy Volunteer Studies
 Table 4. Major Players of Patient Population Studies
 Table 5. First in Human (FIH) Studies Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
 Table 6. Global First in Human (FIH) Studies Market Size by Type (2020-2025) & ($ millions)
 Table 7. Global First in Human (FIH) Studies Market Size Market Share by Type (2020-2025)
 Table 8. First in Human (FIH) Studies Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
 Table 9. Global First in Human (FIH) Studies Market Size by Application (2020-2025) & ($ millions)
 Table 10. Global First in Human (FIH) Studies Market Size Market Share by Application (2020-2025)
 Table 11. Global First in Human (FIH) Studies Revenue by Player (2020-2025) & ($ millions)
 Table 12. Global First in Human (FIH) Studies Revenue Market Share by Player (2020-2025)
 Table 13. First in Human (FIH) Studies Key Players Head office and Products Offered
 Table 14. First in Human (FIH) Studies Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
 Table 15. New Products and Potential Entrants
 Table 16. Mergers & Acquisitions, Expansion
 Table 17. Global First in Human (FIH) Studies Market Size by Region (2020-2025) & ($ millions)
 Table 18. Global First in Human (FIH) Studies Market Size Market Share by Region (2020-2025)
 Table 19. Global First in Human (FIH) Studies Revenue by Country/Region (2020-2025) & ($ millions)
 Table 20. Global First in Human (FIH) Studies Revenue Market Share by Country/Region (2020-2025)
 Table 21. Americas First in Human (FIH) Studies Market Size by Country (2020-2025) & ($ millions)
 Table 22. Americas First in Human (FIH) Studies Market Size Market Share by Country (2020-2025)
 Table 23. Americas First in Human (FIH) Studies Market Size by Type (2020-2025) & ($ millions)
 Table 24. Americas First in Human (FIH) Studies Market Size Market Share by Type (2020-2025)
 Table 25. Americas First in Human (FIH) Studies Market Size by Application (2020-2025) & ($ millions)
 Table 26. Americas First in Human (FIH) Studies Market Size Market Share by Application (2020-2025)
 Table 27. APAC First in Human (FIH) Studies Market Size by Region (2020-2025) & ($ millions)
 Table 28. APAC First in Human (FIH) Studies Market Size Market Share by Region (2020-2025)
 Table 29. APAC First in Human (FIH) Studies Market Size by Type (2020-2025) & ($ millions)
 Table 30. APAC First in Human (FIH) Studies Market Size by Application (2020-2025) & ($ millions)
 Table 31. Europe First in Human (FIH) Studies Market Size by Country (2020-2025) & ($ millions)
 Table 32. Europe First in Human (FIH) Studies Market Size Market Share by Country (2020-2025)
 Table 33. Europe First in Human (FIH) Studies Market Size by Type (2020-2025) & ($ millions)
 Table 34. Europe First in Human (FIH) Studies Market Size by Application (2020-2025) & ($ millions)
 Table 35. Middle East & Africa First in Human (FIH) Studies Market Size by Region (2020-2025) & ($ millions)
 Table 36. Middle East & Africa First in Human (FIH) Studies Market Size by Type (2020-2025) & ($ millions)
 Table 37. Middle East & Africa First in Human (FIH) Studies Market Size by Application (2020-2025) & ($ millions)
 Table 38. Key Market Drivers & Growth Opportunities of First in Human (FIH) Studies
 Table 39. Key Market Challenges & Risks of First in Human (FIH) Studies
 Table 40. Key Industry Trends of First in Human (FIH) Studies
 Table 41. Global First in Human (FIH) Studies Market Size Forecast by Region (2026-2031) & ($ millions)
 Table 42. Global First in Human (FIH) Studies Market Size Market Share Forecast by Region (2026-2031)
 Table 43. Global First in Human (FIH) Studies Market Size Forecast by Type (2026-2031) & ($ millions)
 Table 44. Global First in Human (FIH) Studies Market Size Forecast by Application (2026-2031) & ($ millions)
 Table 45. Precision for Medicine Details, Company Type, First in Human (FIH) Studies Area Served and Its Competitors
 Table 46. Precision for Medicine First in Human (FIH) Studies Product Offered
 Table 47. Precision for Medicine First in Human (FIH) Studies Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 48. Precision for Medicine Main Business
 Table 49. Precision for Medicine Latest Developments
 Table 50. Altasciences Details, Company Type, First in Human (FIH) Studies Area Served and Its Competitors
 Table 51. Altasciences First in Human (FIH) Studies Product Offered
 Table 52. Altasciences First in Human (FIH) Studies Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 53. Altasciences Main Business
 Table 54. Altasciences Latest Developments
 Table 55. hVIVO Details, Company Type, First in Human (FIH) Studies Area Served and Its Competitors
 Table 56. hVIVO First in Human (FIH) Studies Product Offered
 Table 57. hVIVO First in Human (FIH) Studies Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 58. hVIVO Main Business
 Table 59. hVIVO Latest Developments
 Table 60. QPS Holdings Details, Company Type, First in Human (FIH) Studies Area Served and Its Competitors
 Table 61. QPS Holdings First in Human (FIH) Studies Product Offered
 Table 62. QPS Holdings First in Human (FIH) Studies Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 63. QPS Holdings Main Business
 Table 64. QPS Holdings Latest Developments
 Table 65. Worldwide Clinical Trials Details, Company Type, First in Human (FIH) Studies Area Served and Its Competitors
 Table 66. Worldwide Clinical Trials First in Human (FIH) Studies Product Offered
 Table 67. Worldwide Clinical Trials First in Human (FIH) Studies Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 68. Worldwide Clinical Trials Main Business
 Table 69. Worldwide Clinical Trials Latest Developments
 Table 70. Veeda Lifesciences Details, Company Type, First in Human (FIH) Studies Area Served and Its Competitors
 Table 71. Veeda Lifesciences First in Human (FIH) Studies Product Offered
 Table 72. Veeda Lifesciences First in Human (FIH) Studies Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 73. Veeda Lifesciences Main Business
 Table 74. Veeda Lifesciences Latest Developments
 Table 75. CMAX Details, Company Type, First in Human (FIH) Studies Area Served and Its Competitors
 Table 76. CMAX First in Human (FIH) Studies Product Offered
 Table 77. CMAX First in Human (FIH) Studies Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 78. CMAX Main Business
 Table 79. CMAX Latest Developments
 Table 80. Hammersmith Medicines Research Details, Company Type, First in Human (FIH) Studies Area Served and Its Competitors
 Table 81. Hammersmith Medicines Research First in Human (FIH) Studies Product Offered
 Table 82. Hammersmith Medicines Research First in Human (FIH) Studies Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 83. Hammersmith Medicines Research Main Business
 Table 84. Hammersmith Medicines Research Latest Developments
 Table 85. Allucent Details, Company Type, First in Human (FIH) Studies Area Served and Its Competitors
 Table 86. Allucent First in Human (FIH) Studies Product Offered
 Table 87. Allucent First in Human (FIH) Studies Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 88. Allucent Main Business
 Table 89. Allucent Latest Developments
 Table 90. Aixial Group Details, Company Type, First in Human (FIH) Studies Area Served and Its Competitors
 Table 91. Aixial Group First in Human (FIH) Studies Product Offered
 Table 92. Aixial Group First in Human (FIH) Studies Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 93. Aixial Group Main Business
 Table 94. Aixial Group Latest Developments
 Table 95. Icon Group Details, Company Type, First in Human (FIH) Studies Area Served and Its Competitors
 Table 96. Icon Group First in Human (FIH) Studies Product Offered
 Table 97. Icon Group First in Human (FIH) Studies Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 98. Icon Group Main Business
 Table 99. Icon Group Latest Developments
 Table 100. BioPharma Services Details, Company Type, First in Human (FIH) Studies Area Served and Its Competitors
 Table 101. BioPharma Services First in Human (FIH) Studies Product Offered
 Table 102. BioPharma Services First in Human (FIH) Studies Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 103. BioPharma Services Main Business
 Table 104. BioPharma Services Latest Developments
 Table 105. Simbec-Orion Details, Company Type, First in Human (FIH) Studies Area Served and Its Competitors
 Table 106. Simbec-Orion First in Human (FIH) Studies Product Offered
 Table 107. Simbec-Orion First in Human (FIH) Studies Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 108. Simbec-Orion Main Business
 Table 109. Simbec-Orion Latest Developments
 Table 110. The Micron Group Details, Company Type, First in Human (FIH) Studies Area Served and Its Competitors
 Table 111. The Micron Group First in Human (FIH) Studies Product Offered
 Table 112. The Micron Group First in Human (FIH) Studies Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 113. The Micron Group Main Business
 Table 114. The Micron Group Latest Developments
 Table 115. BDD Details, Company Type, First in Human (FIH) Studies Area Served and Its Competitors
 Table 116. BDD First in Human (FIH) Studies Product Offered
 Table 117. BDD First in Human (FIH) Studies Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 118. BDD Main Business
 Table 119. BDD Latest Developments
 Table 120. TRACER Details, Company Type, First in Human (FIH) Studies Area Served and Its Competitors
 Table 121. TRACER First in Human (FIH) Studies Product Offered
 Table 122. TRACER First in Human (FIH) Studies Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 123. TRACER Main Business
 Table 124. TRACER Latest Developments
 Table 125. Sofpromed Details, Company Type, First in Human (FIH) Studies Area Served and Its Competitors
 Table 126. Sofpromed First in Human (FIH) Studies Product Offered
 Table 127. Sofpromed First in Human (FIH) Studies Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 128. Sofpromed Main Business
 Table 129. Sofpromed Latest Developments
 Table 130. Datapharm Australia Details, Company Type, First in Human (FIH) Studies Area Served and Its Competitors
 Table 131. Datapharm Australia First in Human (FIH) Studies Product Offered
 Table 132. Datapharm Australia First in Human (FIH) Studies Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 133. Datapharm Australia Main Business
 Table 134. Datapharm Australia Latest Developments
 Table 135. 3S Pharma Details, Company Type, First in Human (FIH) Studies Area Served and Its Competitors
 Table 136. 3S Pharma First in Human (FIH) Studies Product Offered
 Table 137. 3S Pharma First in Human (FIH) Studies Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 138. 3S Pharma Main Business
 Table 139. 3S Pharma Latest Developments
 Table 140. bioaccess Details, Company Type, First in Human (FIH) Studies Area Served and Its Competitors
 Table 141. bioaccess First in Human (FIH) Studies Product Offered
 Table 142. bioaccess First in Human (FIH) Studies Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 143. bioaccess Main Business
 Table 144. bioaccess Latest Developments
 Table 145. Pharmaron Details, Company Type, First in Human (FIH) Studies Area Served and Its Competitors
 Table 146. Pharmaron First in Human (FIH) Studies Product Offered
 Table 147. Pharmaron First in Human (FIH) Studies Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 148. Pharmaron Main Business
 Table 149. Pharmaron Latest Developments
 Table 150. WuXi Clinical (WuXi AppTec) Details, Company Type, First in Human (FIH) Studies Area Served and Its Competitors
 Table 151. WuXi Clinical (WuXi AppTec) First in Human (FIH) Studies Product Offered
 Table 152. WuXi Clinical (WuXi AppTec) First in Human (FIH) Studies Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 153. WuXi Clinical (WuXi AppTec) Main Business
 Table 154. WuXi Clinical (WuXi AppTec) Latest Developments


List of Figures
 Figure 1. First in Human (FIH) Studies Report Years Considered
 Figure 2. Research Objectives
 Figure 3. Research Methodology
 Figure 4. Research Process and Data Source
 Figure 5. Global First in Human (FIH) Studies Market Size Growth Rate (2020-2031) ($ millions)
 Figure 6. First in Human (FIH) Studies Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
 Figure 7. First in Human (FIH) Studies Sales Market Share by Country/Region (2024)
 Figure 8. First in Human (FIH) Studies Sales Market Share by Country/Region (2020, 2024 & 2031)
 Figure 9. Global First in Human (FIH) Studies Market Size Market Share by Type in 2024
 Figure 10. First in Human (FIH) Studies in Pharmaceutical
 Figure 11. Global First in Human (FIH) Studies Market: Pharmaceutical (2020-2025) & ($ millions)
 Figure 12. First in Human (FIH) Studies in Vaccine
 Figure 13. Global First in Human (FIH) Studies Market: Vaccine (2020-2025) & ($ millions)
 Figure 14. First in Human (FIH) Studies in Others
 Figure 15. Global First in Human (FIH) Studies Market: Others (2020-2025) & ($ millions)
 Figure 16. Global First in Human (FIH) Studies Market Size Market Share by Application in 2024
 Figure 17. Global First in Human (FIH) Studies Revenue Market Share by Player in 2024
 Figure 18. Global First in Human (FIH) Studies Market Size Market Share by Region (2020-2025)
 Figure 19. Americas First in Human (FIH) Studies Market Size 2020-2025 ($ millions)
 Figure 20. APAC First in Human (FIH) Studies Market Size 2020-2025 ($ millions)
 Figure 21. Europe First in Human (FIH) Studies Market Size 2020-2025 ($ millions)
 Figure 22. Middle East & Africa First in Human (FIH) Studies Market Size 2020-2025 ($ millions)
 Figure 23. Americas First in Human (FIH) Studies Value Market Share by Country in 2024
 Figure 24. United States First in Human (FIH) Studies Market Size Growth 2020-2025 ($ millions)
 Figure 25. Canada First in Human (FIH) Studies Market Size Growth 2020-2025 ($ millions)
 Figure 26. Mexico First in Human (FIH) Studies Market Size Growth 2020-2025 ($ millions)
 Figure 27. Brazil First in Human (FIH) Studies Market Size Growth 2020-2025 ($ millions)
 Figure 28. APAC First in Human (FIH) Studies Market Size Market Share by Region in 2024
 Figure 29. APAC First in Human (FIH) Studies Market Size Market Share by Type (2020-2025)
 Figure 30. APAC First in Human (FIH) Studies Market Size Market Share by Application (2020-2025)
 Figure 31. China First in Human (FIH) Studies Market Size Growth 2020-2025 ($ millions)
 Figure 32. Japan First in Human (FIH) Studies Market Size Growth 2020-2025 ($ millions)
 Figure 33. South Korea First in Human (FIH) Studies Market Size Growth 2020-2025 ($ millions)
 Figure 34. Southeast Asia First in Human (FIH) Studies Market Size Growth 2020-2025 ($ millions)
 Figure 35. India First in Human (FIH) Studies Market Size Growth 2020-2025 ($ millions)
 Figure 36. Australia First in Human (FIH) Studies Market Size Growth 2020-2025 ($ millions)
 Figure 37. Europe First in Human (FIH) Studies Market Size Market Share by Country in 2024
 Figure 38. Europe First in Human (FIH) Studies Market Size Market Share by Type (2020-2025)
 Figure 39. Europe First in Human (FIH) Studies Market Size Market Share by Application (2020-2025)
 Figure 40. Germany First in Human (FIH) Studies Market Size Growth 2020-2025 ($ millions)
 Figure 41. France First in Human (FIH) Studies Market Size Growth 2020-2025 ($ millions)
 Figure 42. UK First in Human (FIH) Studies Market Size Growth 2020-2025 ($ millions)
 Figure 43. Italy First in Human (FIH) Studies Market Size Growth 2020-2025 ($ millions)
 Figure 44. Russia First in Human (FIH) Studies Market Size Growth 2020-2025 ($ millions)
 Figure 45. Middle East & Africa First in Human (FIH) Studies Market Size Market Share by Region (2020-2025)
 Figure 46. Middle East & Africa First in Human (FIH) Studies Market Size Market Share by Type (2020-2025)
 Figure 47. Middle East & Africa First in Human (FIH) Studies Market Size Market Share by Application (2020-2025)
 Figure 48. Egypt First in Human (FIH) Studies Market Size Growth 2020-2025 ($ millions)
 Figure 49. South Africa First in Human (FIH) Studies Market Size Growth 2020-2025 ($ millions)
 Figure 50. Israel First in Human (FIH) Studies Market Size Growth 2020-2025 ($ millions)
 Figure 51. Turkey First in Human (FIH) Studies Market Size Growth 2020-2025 ($ millions)
 Figure 52. GCC Countries First in Human (FIH) Studies Market Size Growth 2020-2025 ($ millions)
 Figure 53. Americas First in Human (FIH) Studies Market Size 2026-2031 ($ millions)
 Figure 54. APAC First in Human (FIH) Studies Market Size 2026-2031 ($ millions)
 Figure 55. Europe First in Human (FIH) Studies Market Size 2026-2031 ($ millions)
 Figure 56. Middle East & Africa First in Human (FIH) Studies Market Size 2026-2031 ($ millions)
 Figure 57. United States First in Human (FIH) Studies Market Size 2026-2031 ($ millions)
 Figure 58. Canada First in Human (FIH) Studies Market Size 2026-2031 ($ millions)
 Figure 59. Mexico First in Human (FIH) Studies Market Size 2026-2031 ($ millions)
 Figure 60. Brazil First in Human (FIH) Studies Market Size 2026-2031 ($ millions)
 Figure 61. China First in Human (FIH) Studies Market Size 2026-2031 ($ millions)
 Figure 62. Japan First in Human (FIH) Studies Market Size 2026-2031 ($ millions)
 Figure 63. Korea First in Human (FIH) Studies Market Size 2026-2031 ($ millions)
 Figure 64. Southeast Asia First in Human (FIH) Studies Market Size 2026-2031 ($ millions)
 Figure 65. India First in Human (FIH) Studies Market Size 2026-2031 ($ millions)
 Figure 66. Australia First in Human (FIH) Studies Market Size 2026-2031 ($ millions)
 Figure 67. Germany First in Human (FIH) Studies Market Size 2026-2031 ($ millions)
 Figure 68. France First in Human (FIH) Studies Market Size 2026-2031 ($ millions)
 Figure 69. UK First in Human (FIH) Studies Market Size 2026-2031 ($ millions)
 Figure 70. Italy First in Human (FIH) Studies Market Size 2026-2031 ($ millions)
 Figure 71. Russia First in Human (FIH) Studies Market Size 2026-2031 ($ millions)
 Figure 72. Egypt First in Human (FIH) Studies Market Size 2026-2031 ($ millions)
 Figure 73. South Africa First in Human (FIH) Studies Market Size 2026-2031 ($ millions)
 Figure 74. Israel First in Human (FIH) Studies Market Size 2026-2031 ($ millions)
 Figure 75. Turkey First in Human (FIH) Studies Market Size 2026-2031 ($ millions)
 Figure 76. Global First in Human (FIH) Studies Market Size Market Share Forecast by Type (2026-2031)
 Figure 77. Global First in Human (FIH) Studies Market Size Market Share Forecast by Application (2026-2031)
 Figure 78. GCC Countries First in Human (FIH) Studies Market Size 2026-2031 ($ millions)

Companies Mentioned

Precision for Medicine

Altasciences

hVIVO

QPS Holdings

Worldwide Clinical Trials

Veeda Lifesciences

CMAX

Hammersmith Medicines Research

Allucent

Aixial Group

Icon Group

BioPharma Services

Simbec-Orion

The Micron Group

BDD

TRACER

Sofpromed

Datapharm Australia

3S Pharma

bioaccess

Pharmaron

WuXi Clinical (WuXi AppTec)

Methodology

LP Information presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

Data Sourse

Primary Source

Secondary Source

Players/Suppliers

Journals and Periodicals

Industry Experts

Government Bodies

Distributors/Traders

Annual Reports

Opinion Leaders

Presentations

Front-line Staff